Literature DB >> 2808487

Should elective lymph node dissection be used for treatment of primary melanoma?

B Biess1, E B Bröcker, H Drepper, M Klein, A Lippold, A Peters.   

Abstract

A bicenter study compared survival probability in patients with malignant melanoma clinical stage I, treated by wide excision only or wide excision with elective lymph node dissection (ELND). ELND improved the survival only in men with primary tumors of 1.51-3.0 mm thickness. In female patients those without ELND showed a better survival. Thus, the total group of patients did not benefit from ELND, i.e. its value for the improvement of survival from malignant melanoma stage I could not be statistically proven.

Entities:  

Mesh：

Year:  1989        PMID： 2808487     DOI： 10.1007/bf00393340

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


  20 in total

Review 1.  [Prognostically relevant criteria and stage-related therapy of malignant melanoma].

Authors:  H Drepper; A Grootens; G Padberg; A Peters; H Wiebelt
Journal:  Fortschr Kiefer Gesichtschir       Date:  1988

2.  Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study.

Authors:  F H Sim; W F Taylor; D J Pritchard; E H Soule
Journal:  Mayo Clin Proc       Date:  1986-09       Impact factor: 7.616

3.  [Malignant melanoma: prognostic evaluation using correlation coefficients].

Authors:  C Kühnl-Petzoldt; H Berger; H Wiebelt
Journal:  Hautarzt       Date:  1983-08       Impact factor: 0.751

4.  Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma.

Authors:  D S Reintgen; E B Cox; K S McCarty; R T Vollmer; H F Seigler
Journal:  Ann Surg       Date:  1983-09       Impact factor: 12.969

5.  A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia.

Authors:  C M Balch; S J Soong; G W Milton; H M Shaw; V J McGovern; T M Murad; W H McCarthy; W A Maddox
Journal:  Ann Surg       Date:  1982-12       Impact factor: 12.969

6.  Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities.

Authors:  U Veronesi; J Adamus; D C Bandiera; O Brennhovd; E Caceres; N Cascinelli; F Claudio; R L Ikonopisov; V V Javorski; S Kirov; A Kulakowski; J Lacour; F Lejeune; Z Mechl; A Morabito; I Rodé; S Sergeev; E van Slooten; K Szczygiel; N N Trapeznikov; R I Wagner
Journal:  Cancer       Date:  1982-06-01       Impact factor: 6.860

7.  Surgical management of regional lymph nodes in cutaneous melanoma.

Authors:  C M Balch
Journal:  J Am Acad Dermatol       Date:  1980-11       Impact factor: 11.527

8.  Prognosis of stage I melanoma of the skin. Who collaborating centres for evaluation of methods of diagnosis and treatment of melanoma.

Authors: 
Journal:  Int J Cancer       Date:  1980-12-15       Impact factor: 7.396

9.  A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Preliminary results.

Authors:  F H Sim; W F Taylor; J C Ivins; D J Pritchard; E H Soule
Journal:  Cancer       Date:  1978-03       Impact factor: 6.860

10.  Efficacy of elective lymph node dissection in 2,347 patients with clinical stage I malignant melanoma.

Authors:  W H McCarthy; H M Shaw; G W Milton
Journal:  Surg Gynecol Obstet       Date:  1985-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.